Xin Jie Lim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xin Jie Lim has a total of 114 co-authors. Here are the top co-authors by number of shared publications:
- Chee Tao Chang
Clinical Research Centre, Hospital Raja Permaisuri Bainun, Ministry of Health Malaysia
8 shared publications - Chii-Chii Chew
Hospital Raja Permaisuri Bainun
8 shared publications - Philip Rajan
Department of Otorhinolaryngology, Hospital Raja Permaisuri Bainun, Ipoh, Perak, Malaysia
6 shared publications Philip Rajan
Clinical Research Centre, Hospital Raja Permaisuri Bainun, Ministry of Health, Level 4, Ambulatory Care Centre (ACC), Ipoh, Malaysia
5 shared publications- Jason Choong Yin Lee
Ministry of Health
4 shared publications Chee Ping Chong
Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Minden, Malaysia
3 shared publications
Latest Publications
- Open Access
- 20 October 2026
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 10, e101650
Knowledge, Attitudes, and Practices of Malaysian Pharmacists Regarding AI Adoption: Cross-Sectional Study
Background: AI is increasingly integrated into health care systems worldwide, with growing implications for pharmacy practice. Although studies have reported general perceptions of AI, gaps between awareness and practical implementation remain evident, particularly in middle-income settings. Objective: This study aimed to assess the baseline knowledge, attitudes, and practices (KAP) of Malaysian pharmacists regarding AI adoption in pharmacy practice and identify factors associated with these domains. Methods: A cross-sectional study was conducted using a self-administered online questionnaire distributed to registered pharmacists practicing in Malaysia. The instrument comprised 12 knowledge items, 10 attitude items, and 5 practice items and underwent expert review and pilot testing. KAP scores were categorized using Bloom cutoff points as good (80%-100%), moderate (60%-79%), or poor (<60%). Data were analyzed using R statistical software. Results: A total of 407 pharmacists completed the survey. The median knowledge score was 75 (IQR 67-92), with 42.3% (172/407) of pharmacists demonstrating good knowledge. The median attitude score was 82 (IQR 76-94), and 64.6% (263/407) of pharmacists exhibited positive attitudes toward AI. However, the median practice score was 56 (IQR 44-68), with 54.3% (221/407) of pharmacists classified as having poor AI use in practice. Statistically significant but weak positive correlations were observed among the 3 domains. Pharmacists with postgraduate qualifications demonstrated significantly higher knowledge scores (P=.01). Conclusions: Malaysian pharmacists demonstrated moderate knowledge and positive attitudes toward AI. However, the practical integration of AI into routine pharmacy workflows remained limited. Strengthening institutional support, structured training, and implementation frameworks may be necessary to translate perceived readiness into clinical adoption.
- 20 October 2026
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 10, e101650
Open AccessKnowledge, Attitudes, and Practices of Malaysian Pharmacists Regarding AI Adoption: Cross-Sectional Study
Background: AI is increasingly integrated into health care systems worldwide, with growing implications for pharmacy practice. Although studies have reported general perceptions of AI, gaps between awareness and practical implementation remain evident, particularly in middle-income settings. Objective: This study aimed to assess the baseline knowledge, attitudes, and practices (KAP) of Malaysian pharmacists regarding AI adoption in pharmacy practice and identify factors associated with these domains. Methods: A cross-sectional study was conducted using a self-administered online questionnaire distributed to registered pharmacists practicing in Malaysia. The instrument comprised 12 knowledge items, 10 attitude items, and 5 practice items and underwent expert review and pilot testing. KAP scores were categorized using Bloom cutoff points as good (80%-100%), moderate (60%-79%), or poor (<60%). Data were analyzed using R statistical software. Results: A total of 407 pharmacists completed the survey. The median knowledge score was 75 (IQR 67-92), with 42.3% (172/407) of pharmacists demonstrating good knowledge. The median attitude score was 82 (IQR 76-94), and 64.6% (263/407) of pharmacists exhibited positive attitudes toward AI. However, the median practice score was 56 (IQR 44-68), with 54.3% (221/407) of pharmacists classified as having poor AI use in practice. Statistically significant but weak positive correlations were observed among the 3 domains. Pharmacists with postgraduate qualifications demonstrated significantly higher knowledge scores (P=.01). Conclusions: Malaysian pharmacists demonstrated moderate knowledge and positive attitudes toward AI. However, the practical integration of AI into routine pharmacy workflows remained limited. Strengthening institutional support, structured training, and implementation frameworks may be necessary to translate perceived readiness into clinical adoption.
- 26 May 2026
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 57 (1)
Colorectal Cancer Screening in Malaysia: Understanding the iFOBT-to-Colonoscopy Gap
Colorectal cancer (CRC) remains a major public health burden in Malaysia. Although the national immunochemical faecal occult blood test (iFOBT) screening programme has expanded substantially in recent years, completion of diagnostic colonoscopy following a positive iFOBT result remains persistently low. This commentary examines the persistent iFOBT-to-colonoscopy gap in Malaysia and proposes an integrated conceptual framework to guide interventions that improve diagnostic follow-up. National and community-based studies demonstrate increasing iFOBT uptake but consistently suboptimal colonoscopy completion rates despite meaningful detection of colorectal cancer and polyps. Existing evidence suggests that fear, procedural anxiety, financial and logistical barriers, poor awareness, fragmented referral systems, and weak care coordination contribute to attrition along the screening pathway. To address these challenges, this commentary integrates the Health Belief Model (HBM) with the socio-ecological model (SEM) to illustrate how behavioural beliefs are influenced by interpersonal, organisational, community, and policy-level factors. The framework highlights the importance of coordinated interventions including patient navigation, reminder systems, provider engagement, digital referral tracking, community outreach, and public-private collaboration. Improving colonoscopy completion after positive iFOBT results requires a coordinated multi-level systems approach that addresses both behavioural and structural barriers to strengthen continuity across the CRC screening continuum.
- 26 May 2026
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 57 (1)
Colorectal Cancer Screening in Malaysia: Understanding the iFOBT-to-Colonoscopy Gap
Colorectal cancer (CRC) remains a major public health burden in Malaysia. Although the national immunochemical faecal occult blood test (iFOBT) screening programme has expanded substantially in recent years, completion of diagnostic colonoscopy following a positive iFOBT result remains persistently low. This commentary examines the persistent iFOBT-to-colonoscopy gap in Malaysia and proposes an integrated conceptual framework to guide interventions that improve diagnostic follow-up. National and community-based studies demonstrate increasing iFOBT uptake but consistently suboptimal colonoscopy completion rates despite meaningful detection of colorectal cancer and polyps. Existing evidence suggests that fear, procedural anxiety, financial and logistical barriers, poor awareness, fragmented referral systems, and weak care coordination contribute to attrition along the screening pathway. To address these challenges, this commentary integrates the Health Belief Model (HBM) with the socio-ecological model (SEM) to illustrate how behavioural beliefs are influenced by interpersonal, organisational, community, and policy-level factors. The framework highlights the importance of coordinated interventions including patient navigation, reminder systems, provider engagement, digital referral tracking, community outreach, and public-private collaboration. Improving colonoscopy completion after positive iFOBT results requires a coordinated multi-level systems approach that addresses both behavioural and structural barriers to strengthen continuity across the CRC screening continuum.
- Open Access
- 18 May 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Knowledge, Attitudes, and Practices of Malaysian Pharmacists Regarding AI Adoption: Cross-Sectional Study (Preprint)
BACKGROUND AI is increasingly integrated into health care systems worldwide, with growing implications for pharmacy practice. Although studies have reported general perceptions of AI, gaps between awareness and practical implementation remain evident, particularly in middle-income settings. OBJECTIVE This study aimed to assess the baseline knowledge, attitudes, and practices (KAP) of Malaysian pharmacists regarding AI adoption in pharmacy practice and identify factors associated with these domains. METHODS A cross-sectional study was conducted using a self-administered online questionnaire distributed to registered pharmacists practicing in Malaysia. The instrument comprised 12 knowledge items, 10 attitude items, and 5 practice items and underwent expert review and pilot testing. KAP scores were categorized using Bloom cutoff points as good (80%-100%), moderate (60%-79%), or poor (<60%). Data were analyzed using R statistical software. RESULTS A total of 407 pharmacists completed the survey. The median knowledge score was 75 (IQR 67-92), with 42.3% (172/407) of pharmacists demonstrating good knowledge. The median attitude score was 82 (IQR 76-94), and 64.6% (263/407) of pharmacists exhibited positive attitudes toward AI. However, the median practice score was 56 (IQR 44-68), with 54.3% (221/407) of pharmacists classified as having poor AI use in practice. Statistically significant but weak positive correlations were observed among the 3 domains. Pharmacists with postgraduate qualifications demonstrated significantly higher knowledge scores (P=.01). CONCLUSIONS Malaysian pharmacists demonstrated moderate knowledge and positive attitudes toward AI. However, the practical integration of AI into routine pharmacy workflows remained limited. Strengthening institutional support, structured training, and implementation frameworks may be necessary to translate perceived readiness into clinical adoption.
- 18 May 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessKnowledge, Attitudes, and Practices of Malaysian Pharmacists Regarding AI Adoption: Cross-Sectional Study (Preprint)
BACKGROUND AI is increasingly integrated into health care systems worldwide, with growing implications for pharmacy practice. Although studies have reported general perceptions of AI, gaps between awareness and practical implementation remain evident, particularly in middle-income settings. OBJECTIVE This study aimed to assess the baseline knowledge, attitudes, and practices (KAP) of Malaysian pharmacists regarding AI adoption in pharmacy practice and identify factors associated with these domains. METHODS A cross-sectional study was conducted using a self-administered online questionnaire distributed to registered pharmacists practicing in Malaysia. The instrument comprised 12 knowledge items, 10 attitude items, and 5 practice items and underwent expert review and pilot testing. KAP scores were categorized using Bloom cutoff points as good (80%-100%), moderate (60%-79%), or poor (<60%). Data were analyzed using R statistical software. RESULTS A total of 407 pharmacists completed the survey. The median knowledge score was 75 (IQR 67-92), with 42.3% (172/407) of pharmacists demonstrating good knowledge. The median attitude score was 82 (IQR 76-94), and 64.6% (263/407) of pharmacists exhibited positive attitudes toward AI. However, the median practice score was 56 (IQR 44-68), with 54.3% (221/407) of pharmacists classified as having poor AI use in practice. Statistically significant but weak positive correlations were observed among the 3 domains. Pharmacists with postgraduate qualifications demonstrated significantly higher knowledge scores (P=.01). CONCLUSIONS Malaysian pharmacists demonstrated moderate knowledge and positive attitudes toward AI. However, the practical integration of AI into routine pharmacy workflows remained limited. Strengthening institutional support, structured training, and implementation frameworks may be necessary to translate perceived readiness into clinical adoption.
- 11 November 2025
- Published by SAGE Publications in Asia Pacific Journal of Public Health
- Vol. 37 (8) , 690-697
An Evaluation of the Effectiveness of Patient Navigation on Colonoscopy Screening Adherence for Colorectal Cancer: A Randomized Controlled Trial
Despite effective screening tools, colorectal cancer (CRC) screening uptake remains low in Malaysia. We aimed to determine whether a locally contextualized patient navigation programme could improve adherence to and reduce the psychological impact of screening colonoscopy. A pilot study determined barriers to colonoscopy adherence. The navigation programme was developed (phase 1), and navigators trained (phase 2). Fifty-two average-risk patients with positive immunochemical faecal occult blood tests were randomized to the patient navigation programme (intervention) or standard care (control) (phase 3). The primary outcome was adherence to colonoscopy. Secondary outcomes, assessed pre-colonoscopy and post-colonoscopy, used the Hospital Anxiety and Depression Scale (HADS) and General Health Questionnaire-12 (GHQ-12) scores. Navigated patients were 2.4 times more likely to complete colonoscopy ( P < .001), had significant reduction in anxiety ( P < .001) and depression ( P = .008) while general wellbeing was better ( P < .001) compared with controls. This culturally contextualized navigation programme is effective in improving adherence to colonoscopy, with reduction in anxiety, depression and general psychological distress. Wider implementation should be considered in national CRC screening strategies to improve effectiveness.
- 11 November 2025
- Published by SAGE Publications in Asia Pacific Journal of Public Health
- Vol. 37 (8) , 690-697
An Evaluation of the Effectiveness of Patient Navigation on Colonoscopy Screening Adherence for Colorectal Cancer: A Randomized Controlled Trial
Despite effective screening tools, colorectal cancer (CRC) screening uptake remains low in Malaysia. We aimed to determine whether a locally contextualized patient navigation programme could improve adherence to and reduce the psychological impact of screening colonoscopy. A pilot study determined barriers to colonoscopy adherence. The navigation programme was developed (phase 1), and navigators trained (phase 2). Fifty-two average-risk patients with positive immunochemical faecal occult blood tests were randomized to the patient navigation programme (intervention) or standard care (control) (phase 3). The primary outcome was adherence to colonoscopy. Secondary outcomes, assessed pre-colonoscopy and post-colonoscopy, used the Hospital Anxiety and Depression Scale (HADS) and General Health Questionnaire-12 (GHQ-12) scores. Navigated patients were 2.4 times more likely to complete colonoscopy ( P < .001), had significant reduction in anxiety ( P < .001) and depression ( P = .008) while general wellbeing was better ( P < .001) compared with controls. This culturally contextualized navigation programme is effective in improving adherence to colonoscopy, with reduction in anxiety, depression and general psychological distress. Wider implementation should be considered in national CRC screening strategies to improve effectiveness.
- Open Access
- 16 September 2024
- Published by Taylor & Francis in Journal of Pharmaceutical Policy and Practice
- Vol. 17 (1) , 2399727
Factors influencing healthcare providers’ behaviours in deprescribing: a cross-sectional study
Deprescribing serves as a pivotal measure to mitigate the drug-related problem due to polypharmacy. This study aimed to map the factors influencing healthcare providers' deprescribing decision using the Behaviour Change Wheel framework and develop an innovative conceptual model to support deprescribing practice. A cross-sectional online survey targeting doctors and pharmacists was conducted to assess the influence of various factors on healthcare providers' comfort in recommending deprescribing. The conceptual model was formulated, based on the existing deprescribing framework and the Behaviour Change Wheel. The model's robustness was scrutinised through Partial Least Squares Structural Equation Modeling (PLS-SEM), and model-fitting indices were employed to obtain the best-fit model. A total of 736 responses were analysed with the final best-fit model consisting of 24 items in 5 constructs (R 2: 0.163; SRMR: 0.064; rho_c: 0.750-0.862; AVE: 0.509-0.627) and three independent factors. Based on the results, we proposed that deprescribing could be promoted through strategies aimed at enhancing healthcare providers internal capabilities such as knowledge levels, when patients' condition deteriorated and previous experiences with adverse events of drugs. Organisational support in providing such educational opportunities is important, with the empowerment of patient and healthcare providers through policy enhancements, guideline development, and effective communication. The deprescribing behaviours of healthcare professionals are influenced by an intricate interplay of patient, prescriber, and system factors. Enhancing deprescribing practices necessitates a comprehensive strategy that encompasses providers and patients' education, the development of structured deprescribing guidelines, the implementation of deprescribing support tools, and the enhancement of communication between healthcare providers.
- 16 September 2024
- Published by Taylor & Francis in Journal of Pharmaceutical Policy and Practice
- Vol. 17 (1) , 2399727
Open AccessFactors influencing healthcare providers’ behaviours in deprescribing: a cross-sectional study
Deprescribing serves as a pivotal measure to mitigate the drug-related problem due to polypharmacy. This study aimed to map the factors influencing healthcare providers' deprescribing decision using the Behaviour Change Wheel framework and develop an innovative conceptual model to support deprescribing practice. A cross-sectional online survey targeting doctors and pharmacists was conducted to assess the influence of various factors on healthcare providers' comfort in recommending deprescribing. The conceptual model was formulated, based on the existing deprescribing framework and the Behaviour Change Wheel. The model's robustness was scrutinised through Partial Least Squares Structural Equation Modeling (PLS-SEM), and model-fitting indices were employed to obtain the best-fit model. A total of 736 responses were analysed with the final best-fit model consisting of 24 items in 5 constructs (R 2: 0.163; SRMR: 0.064; rho_c: 0.750-0.862; AVE: 0.509-0.627) and three independent factors. Based on the results, we proposed that deprescribing could be promoted through strategies aimed at enhancing healthcare providers internal capabilities such as knowledge levels, when patients' condition deteriorated and previous experiences with adverse events of drugs. Organisational support in providing such educational opportunities is important, with the empowerment of patient and healthcare providers through policy enhancements, guideline development, and effective communication. The deprescribing behaviours of healthcare professionals are influenced by an intricate interplay of patient, prescriber, and system factors. Enhancing deprescribing practices necessitates a comprehensive strategy that encompasses providers and patients' education, the development of structured deprescribing guidelines, the implementation of deprescribing support tools, and the enhancement of communication between healthcare providers.
- Open Access
- 25 April 2024
- Published by Springer Nature in Trials
- Vol. 25 (1) , 1-15
The effectiveness of pharmacist-led educational model in adult patients with allergic rhinitis: a single-center randomized control trial protocol (AR-PRISE RCT)
Background: Allergic rhinitis is a chronic respiratory disorder that significantly impacts patients’ quality of life (QoL) and work performance. Pharmacists are recognized as suitable professionals to provide patient education and pharmaceutical care for managing allergic rhinitis patients. However, local clinical practice guidelines, particularly regarding pharmaceutical care in public healthcare institutions, are lacking. This study protocol outlines a randomized controlled trial (RCT) designed to evaluate the effectiveness of a pharmacist-led educational model (AR-PRISE Model) in managing allergic rhinitis in adult patients compared to standard pharmaceutical care. The AR-PRISE model delivers patient educational material and a pharmaceutical care algorithm. Method: This is a 6-month, single-center, prospective, randomized, two-arm, and parallel-group controlled trial. The trial recruits patients attending the otorhinolaryngology clinics of a tertiary referral hospital. Participants are randomized into control or intervention groups in a 1:1 ratio using permuted block randomization. The total number of participants estimated is 154, with each group requiring 77 participants. The control group receives standard pharmaceutical care, while the intervention group receives pharmacist-led education according to the AR-PRISE model. Both groups are assessed for middle turbinate endoscopy findings, disease severity, knowledge level, symptom control, medication adherence, and QoL at baseline and the end-of-study follow-up (day 180 ± 7). Depending on feasibility, intermediate follow-ups are conducted on days 60 ± 7 and 120 ± 7, either virtually or face-to-face. During intermediate follow-ups, participants are assessed for symptom control, medication adherence, and QoL. The intention-to-treat analysis includes all participants assigned to each group. An independent T-test compares the mean difference in knowledge level between the two groups. A two-way repeated measures ANOVA analysis is employed to determine between-group differences for scores of symptom control, adherence rate, and QoL. A P-value < 0.05 is considered statistically significant. Discussion: This study protocol will provide a framework for conducting a randomized controlled trial (RCT) to evaluate the effectiveness of pharmacist-led education intervention in managing allergic rhinitis within public healthcare settings. The parameters measured in this trial will quantify outcomes associated with improvements in symptoms and QoL. By systematically assessing these outcomes, we aim to contribute valuable insights into the role of pharmacist-led interventions in enhancing the management of allergic rhinitis in public healthcare settings. Trial registration: ClinicalTrials.gov NCT06027736. Registered on 9 July 2023—retrospectively registered.
- 25 April 2024
- Published by Springer Nature in Trials
- Vol. 25 (1) , 1-15
Open AccessThe effectiveness of pharmacist-led educational model in adult patients with allergic rhinitis: a single-center randomized control trial protocol (AR-PRISE RCT)
Background: Allergic rhinitis is a chronic respiratory disorder that significantly impacts patients’ quality of life (QoL) and work performance. Pharmacists are recognized as suitable professionals to provide patient education and pharmaceutical care for managing allergic rhinitis patients. However, local clinical practice guidelines, particularly regarding pharmaceutical care in public healthcare institutions, are lacking. This study protocol outlines a randomized controlled trial (RCT) designed to evaluate the effectiveness of a pharmacist-led educational model (AR-PRISE Model) in managing allergic rhinitis in adult patients compared to standard pharmaceutical care. The AR-PRISE model delivers patient educational material and a pharmaceutical care algorithm. Method: This is a 6-month, single-center, prospective, randomized, two-arm, and parallel-group controlled trial. The trial recruits patients attending the otorhinolaryngology clinics of a tertiary referral hospital. Participants are randomized into control or intervention groups in a 1:1 ratio using permuted block randomization. The total number of participants estimated is 154, with each group requiring 77 participants. The control group receives standard pharmaceutical care, while the intervention group receives pharmacist-led education according to the AR-PRISE model. Both groups are assessed for middle turbinate endoscopy findings, disease severity, knowledge level, symptom control, medication adherence, and QoL at baseline and the end-of-study follow-up (day 180 ± 7). Depending on feasibility, intermediate follow-ups are conducted on days 60 ± 7 and 120 ± 7, either virtually or face-to-face. During intermediate follow-ups, participants are assessed for symptom control, medication adherence, and QoL. The intention-to-treat analysis includes all participants assigned to each group. An independent T-test compares the mean difference in knowledge level between the two groups. A two-way repeated measures ANOVA analysis is employed to determine between-group differences for scores of symptom control, adherence rate, and QoL. A P-value < 0.05 is considered statistically significant. Discussion: This study protocol will provide a framework for conducting a randomized controlled trial (RCT) to evaluate the effectiveness of pharmacist-led education intervention in managing allergic rhinitis within public healthcare settings. The parameters measured in this trial will quantify outcomes associated with improvements in symptoms and QoL. By systematically assessing these outcomes, we aim to contribute valuable insights into the role of pharmacist-led interventions in enhancing the management of allergic rhinitis in public healthcare settings. Trial registration: ClinicalTrials.gov NCT06027736. Registered on 9 July 2023—retrospectively registered.
- Open Access
- 4 March 2024
- Published by Elsevier in Archives of Gerontology and Geriatrics Plus
- Vol. 1 (2)
COVID-19 related health literacy and preventive behaviours of the older person in Perak state, Malaysia: A qualitative study
- 4 March 2024
- Published by Elsevier in Archives of Gerontology and Geriatrics Plus
- Vol. 1 (2)
Open AccessCOVID-19 related health literacy and preventive behaviours of the older person in Perak state, Malaysia: A qualitative study
- Open Access
- 31 December 2023
- Published by Taylor & Francis in Journal of Pharmaceutical Policy and Practice
- Vol. 16 (1) , 1-12
Development and validation of a pharmacist-led education model in allergic rhinitis management: a multi-phase study
Patient education is identified as one of the core and fundamental management strategies in the management of allergic rhinitis. The Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines developed guidance for the management of allergic respiratory disease, and the guidelines are applicable to the international context. The ARIA guidelines for the pharmacy have specifically encouraged the creation of local pharmacist-led intervention in allergic rhinitis management. This study aims to develop a pharmacist-led educational model using a multi-phase study approach. In phase one, we conducted a literature review using four databases to extract relevant articles and clinical practice guidelines published between 2017 and 2022. The information was structured into a questionnaire consisting of patient education material (10 domains with 130 items) and pharmacist counseling scopes (15 domains with 43 items), with each item having a rating scale ranging from 1 (lowest) to 9 (highest) level of agreement. Fifty-two panellists, including otorhinolaryngologists and pharmacists, were invited to complete the questionnaire. A consensus agreement was considered when at least 70% of panellists scored 7 to 9 (critically important). A two-round survey was conducted, and descriptive analysis, inter-rater reliability (≥ 0.5–1 indicate moderate to excellent reliability), variation in the relative interquartile (VRIR < 0.3 indicate good stability), and variation in the coefficient of variation (VCV < 40% considered consensus achieved) were performed. In phase two, patient education material was developed into audio-visual format, and in phase three, patients rated its understandability and actionability using a validated Patient Education Materials Assessment Tool. In the round one Delphi survey, 43 panellists responded, with 171 out of 173 items achieving “consensus agreement” (75.4–100%). In the second survey, 32 out of 43 panellists responded, with most items (171 out of 173 items) stable across rounds and all items had acceptable internal consistency (VCV: − 12.21–15.81). Two items did not achieve “consensus agreement” (64%) but improved in round two (92.9%), however, instability was observed (VRIR: 0.36). These two items were retained in the model due to achieving the minimum level of agreement and internal consistency (VCV = 15.81). Inter-rater reliability was 0.608 and 0.970 in the respective rounds. Patients rated the educational material as understandable (81.8–100%) and actionable (100%). The validated pharmacist-led education model, with its educational materials tested on end-users, provides structured patient education and pharmaceutical care in assisting patients with allergic rhinitis. The educational material allows the delivery of standardized information by the healthcare providers to the patients. Further research on the effectiveness of this model in improving patients’ symptom control and quality of life is warranted.
- 31 December 2023
- Published by Taylor & Francis in Journal of Pharmaceutical Policy and Practice
- Vol. 16 (1) , 1-12
Open AccessDevelopment and validation of a pharmacist-led education model in allergic rhinitis management: a multi-phase study
Patient education is identified as one of the core and fundamental management strategies in the management of allergic rhinitis. The Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines developed guidance for the management of allergic respiratory disease, and the guidelines are applicable to the international context. The ARIA guidelines for the pharmacy have specifically encouraged the creation of local pharmacist-led intervention in allergic rhinitis management. This study aims to develop a pharmacist-led educational model using a multi-phase study approach. In phase one, we conducted a literature review using four databases to extract relevant articles and clinical practice guidelines published between 2017 and 2022. The information was structured into a questionnaire consisting of patient education material (10 domains with 130 items) and pharmacist counseling scopes (15 domains with 43 items), with each item having a rating scale ranging from 1 (lowest) to 9 (highest) level of agreement. Fifty-two panellists, including otorhinolaryngologists and pharmacists, were invited to complete the questionnaire. A consensus agreement was considered when at least 70% of panellists scored 7 to 9 (critically important). A two-round survey was conducted, and descriptive analysis, inter-rater reliability (≥ 0.5–1 indicate moderate to excellent reliability), variation in the relative interquartile (VRIR < 0.3 indicate good stability), and variation in the coefficient of variation (VCV < 40% considered consensus achieved) were performed. In phase two, patient education material was developed into audio-visual format, and in phase three, patients rated its understandability and actionability using a validated Patient Education Materials Assessment Tool. In the round one Delphi survey, 43 panellists responded, with 171 out of 173 items achieving “consensus agreement” (75.4–100%). In the second survey, 32 out of 43 panellists responded, with most items (171 out of 173 items) stable across rounds and all items had acceptable internal consistency (VCV: − 12.21–15.81). Two items did not achieve “consensus agreement” (64%) but improved in round two (92.9%), however, instability was observed (VRIR: 0.36). These two items were retained in the model due to achieving the minimum level of agreement and internal consistency (VCV = 15.81). Inter-rater reliability was 0.608 and 0.970 in the respective rounds. Patients rated the educational material as understandable (81.8–100%) and actionable (100%). The validated pharmacist-led education model, with its educational materials tested on end-users, provides structured patient education and pharmaceutical care in assisting patients with allergic rhinitis. The educational material allows the delivery of standardized information by the healthcare providers to the patients. Further research on the effectiveness of this model in improving patients’ symptom control and quality of life is warranted.
- Open Access
- 31 December 2023
- Published by Taylor & Francis in Journal of Pharmaceutical Policy and Practice
- Vol. 16 (1) , 1-8
Impact of deprescribing intervention on potentially inappropriate medications and clinical outcomes among hospitalized older adults in Malaysia: a randomized controlled trial (REVMED RCT) protocol
Polypharmacy and the use of potentially inappropriate medications (PIMs) are prevalent among older patients admitted to hospitals, posing a heightened risk of adverse drug events. This trial aims to evaluate the effectiveness of a pharmacist-led deprescribing intervention in reducing medications, PIM and improving clinical outcomes, using the locally developed Malaysian Potentially Inappropriate Prescribing Screening tool in Older Adults (MALPIP). This is an 18-month cluster-randomized, open-label, parallel-arm controlled trial conducted at 14 public hospitals in the Perak state of Malaysia. Patients aged 60 and above, who have at least one medication and one comorbidity are eligible. A stratified-cluster randomization design is employed, with 7 hospitals assigned to the control arm and 7 hospitals assigned to the intervention arm. The MALPIP screening tool will be used in the intervention group to review the medications. If PIM is detected, the pharmacists will discuss with doctors and decide whether to stop or reduce the dose. The primary outcomes of this trial are the total number of medications and number of PIM. The secondary outcomes include fall, emergency department visits, readmissions, quality of life and mortality. Outcomes will be measured during enrolment, discharge, 6, 12, and 18 months. This REVMED trial aims to test the hypothesis that a pharmacist-led deprescribing intervention initiated in the hospital will reduce the total number of medications and PIM 18 months after hospital discharge, reducing fall, emergency department visits, readmissions, mortality and lead to improvement in quality of life. Trial findings will quantify the clinical outcomes associated with reducing medications and PIM for hospitalized older adults with polypharmacy. Trial registration number: This trial was prospectively registered at clinicaltrials.gov (NCT05875623) on the 25th of May 2023. NCT05875623 Clinicaltrials.gov URL: NCT05875623 registered on 25th July 2023.
- 31 December 2023
- Published by Taylor & Francis in Journal of Pharmaceutical Policy and Practice
- Vol. 16 (1) , 1-8
Open AccessImpact of deprescribing intervention on potentially inappropriate medications and clinical outcomes among hospitalized older adults in Malaysia: a randomized controlled trial (REVMED RCT) protocol
Polypharmacy and the use of potentially inappropriate medications (PIMs) are prevalent among older patients admitted to hospitals, posing a heightened risk of adverse drug events. This trial aims to evaluate the effectiveness of a pharmacist-led deprescribing intervention in reducing medications, PIM and improving clinical outcomes, using the locally developed Malaysian Potentially Inappropriate Prescribing Screening tool in Older Adults (MALPIP). This is an 18-month cluster-randomized, open-label, parallel-arm controlled trial conducted at 14 public hospitals in the Perak state of Malaysia. Patients aged 60 and above, who have at least one medication and one comorbidity are eligible. A stratified-cluster randomization design is employed, with 7 hospitals assigned to the control arm and 7 hospitals assigned to the intervention arm. The MALPIP screening tool will be used in the intervention group to review the medications. If PIM is detected, the pharmacists will discuss with doctors and decide whether to stop or reduce the dose. The primary outcomes of this trial are the total number of medications and number of PIM. The secondary outcomes include fall, emergency department visits, readmissions, quality of life and mortality. Outcomes will be measured during enrolment, discharge, 6, 12, and 18 months. This REVMED trial aims to test the hypothesis that a pharmacist-led deprescribing intervention initiated in the hospital will reduce the total number of medications and PIM 18 months after hospital discharge, reducing fall, emergency department visits, readmissions, mortality and lead to improvement in quality of life. Trial findings will quantify the clinical outcomes associated with reducing medications and PIM for hospitalized older adults with polypharmacy. Trial registration number: This trial was prospectively registered at clinicaltrials.gov (NCT05875623) on the 25th of May 2023. NCT05875623 Clinicaltrials.gov URL: NCT05875623 registered on 25th July 2023.
- Open Access
- 6 June 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (6) , e0286638
Perceived unmet needs of an age-friendly environment: A qualitative exploration of older adults’ perspectives in a Malaysian city
This exploratory qualitative study investigates older adults’ unmet needs in the age-friendly city of Ipoh, Malaysia. Seventeen participants were interviewed, including ten older adults residing in Ipoh City for at least six months, four carers, and three professional key informants. Interviews were conducted using semi-structured questions based on the WHO Age-Friendly Cities Framework. A 5P framework for active ageing based on the ecological ageing model was adapted for data analysis. The 5P framework consists of domains of person (micro), process (meso), place (macro), policymaking (macro), and prime, which allows for the dissection of older adults’ unmet needs in planning for multilevel approaches, which were employed for analysis. Person: the personal needs requiring improvement included digital divide disparity, inadequate family support, and restricted sports activities attributed to physical limitations. Process: There were fewer social activities and a lack of low-cost and easily accessible venues for seniors. Economic challenges include expensive private healthcare services, variation in the quality of care in older residential care facilities, and limited savings for retirement. Place issues include unequal distribution of exercise equipment, public open spaces, the need for more conducive parking for seniors, and a place for social activities. Difficulties assessing public transportation, digitalized services, and unaffordable e-hailing services are common among seniors. Housing issues for seniors include a lack of barrier-free housing design and unaffordable housing. Policymaking: Insufficient private sector commitment to improving services to older adults, lack of policy governance on the quality of nursing homes, and insufficient multidisciplinary governance collaboration. Prime: Health promotion for preventing age-related illness is required to preserve health in old age, and full-time family caregivers’ psychological well-being is often overlooked.
- 6 June 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (6) , e0286638
Open AccessPerceived unmet needs of an age-friendly environment: A qualitative exploration of older adults’ perspectives in a Malaysian city
This exploratory qualitative study investigates older adults’ unmet needs in the age-friendly city of Ipoh, Malaysia. Seventeen participants were interviewed, including ten older adults residing in Ipoh City for at least six months, four carers, and three professional key informants. Interviews were conducted using semi-structured questions based on the WHO Age-Friendly Cities Framework. A 5P framework for active ageing based on the ecological ageing model was adapted for data analysis. The 5P framework consists of domains of person (micro), process (meso), place (macro), policymaking (macro), and prime, which allows for the dissection of older adults’ unmet needs in planning for multilevel approaches, which were employed for analysis. Person: the personal needs requiring improvement included digital divide disparity, inadequate family support, and restricted sports activities attributed to physical limitations. Process: There were fewer social activities and a lack of low-cost and easily accessible venues for seniors. Economic challenges include expensive private healthcare services, variation in the quality of care in older residential care facilities, and limited savings for retirement. Place issues include unequal distribution of exercise equipment, public open spaces, the need for more conducive parking for seniors, and a place for social activities. Difficulties assessing public transportation, digitalized services, and unaffordable e-hailing services are common among seniors. Housing issues for seniors include a lack of barrier-free housing design and unaffordable housing. Policymaking: Insufficient private sector commitment to improving services to older adults, lack of policy governance on the quality of nursing homes, and insufficient multidisciplinary governance collaboration. Prime: Health promotion for preventing age-related illness is required to preserve health in old age, and full-time family caregivers’ psychological well-being is often overlooked.